Telix Pharmaceuticals Ltd (TLX) Earning Prediction
Telix Pharmaceuticals Ltd (TLX) is set to release its earnings performance on 02/20 ET in Pre-Market trading. Consensus forecasts predict a revenue of 207.70M and an earnings per share (EPS) of 0.04 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
TLX Transcript
The earnings call reveals strong financial performance with a 63% revenue increase, stable gross margins, and a healthy cash position. The company's expansion and new product developments, such as the BiPASS study and Zircaix approvals, signal future growth. Despite risks like SEC inquiries and pricing pressures, the strategic integration of RLS and global manufacturing investments support a positive outlook. While the Q&A section lacks clarity, overall, the positive financial and strategic developments suggest a likely stock price increase in the coming weeks.
TLX Report
Frequently Asked Questions
What is the Telix Pharmaceuticals Ltd Earnings Release Date and Time?
Telix Pharmaceuticals Ltd (TLX) is scheduled to release its earnings report onFeb 20, 2026, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Telix Pharmaceuticals Ltd Revenue and EPS?
Analysts' consensus predicts 207.70M in revenue and an EPS of 0.04 for Telix Pharmaceuticals Ltd's .
What Does Intellectia's AI Predict for Telix Pharmaceuticals Ltd Earnings?
Intellectia's exclusive AI algorithms forecast a forTelix Pharmaceuticals Ltd's earnings, with a prediction date of Feb 20, 2026. Telix Pharmaceuticals Ltd
How Can I Use This Earnings Prediction to Trade TLX Stock?
Leverage Intellectia's AI forecast to position trades ahead of theFeb 20, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Telix Pharmaceuticals Ltd ?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
